RO7296682
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RO7296682, covering 2024-03-04 to 2025-05-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of RO7296682 in Combination With Atezolizumab in Participants With Advanced Solid Tumors. [Phase 1]